Ageism In Indonesia'S National Covid-19 Vaccination Programme

Concern about vaccine nationalism is well founded,1 but it has overshadowed another form of injustice: vaccine ageism.\n\nIn many low and middle income countries (LMICs) Sinovac is currently the main covid-19 vaccine. Initial Sinovac trials in China were only conducted on adults aged under 60.2 Because of a lack of published evidence, the government of Indonesia has decided to exclude people aged 60 and over from its initial vaccine rollout.3\n\nFurther trials of …